Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFNAR2-IL10RB readthrough is a naturally occurring transcript generated by splicing between the neighboring IFNAR2 and IL10RB genes on chromosome 21, resulting in a chimeric mRNA that encodes a fusion protein combining parts of both gene products. While IFNAR2 and IL10RB encode receptors critical for antiviral and immune signaling, the function, tissue expression, and clinical significance of the IFNAR2-IL10RB readthrough are not established. It is cataloged in gene/protein databases as a protein-coding gene, but there is no evidence that this readthrough protein exists or functions as a discrete, druggable receptor in vivo. Disease associations cited for this locus pertain to the parental genes, and the readthrough product itself is not a standard target in pharmacological research.
None known or established for the readthrough protein.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IFNAR2-IL10RB readthrough protein (IFNAR2-IL10RB).